Dividat

Feusisberg, Switzerland

Dividat is a Spin-off company from the ETH Zurich and develops evidence based training concepts to improve mobility in older adults for prevention and rehabilitation. As a spin-off company of ETH Zurich, their solutions are inspired by recent research articles. On a regular basis, their solutions are evaluated in field trials under consideration of the guidelines of international scientific journals.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Dividat on @MedStartr Today #Geriatrics #HealthyAging #AgeRelatedFunctionalDecline #Rehabilitation #GeriatricMedicine #MedMo #MedStartrVentures

https://www.medstartr.ai/s/iyCQm2-l7BY

Get Involved in Dividat

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: dividat.com/

Disease Areas

Geriatrics Healthy Aging Age-Related Functional Decline Rehabilitation

Technologies

Rehabilitation TechnologyEvidence-Based TherapyHealth Technology

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Dividat?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.